| Literature DB >> 26650402 |
Yi Gao1, Xiaojun Zhang1, Jiankai Wei1,2, Xiaoqing Sun1,2, Jianbo Yuan1, Fuhua Li1, Jianhai Xiang1.
Abstract
Molting is one of the most important biological processes in shrimp growth and development. All shrimp undergo cyclic molting periodically to shed and replace their exoskeletons. This process is essential for growth, metamorphosis, and reproduction in shrimp. However, the molecular mechanisms underlying shrimp molting remain poorly understood. In this study, we investigated global expression changes in the transcriptomes of the Pacific white shrimp, Litopenaeus vannamei, the most commonly cultured shrimp species worldwide. The transcriptome of whole L. vannamei was investigated by RNA-sequencing (RNA-seq) throughout the molting cycle, including the inter-molt (C), pre-molt (D0, D1, D2, D3, D4), and post-molt (P1 and P2) stages, and 93,756 unigenes were identified. Among these genes, we identified 5,117 genes differentially expressed (log2ratio ≥1 and FDR ≤0.001) in adjacent molt stages. The results were compared against the National Center for Biotechnology Information (NCBI) non-redundant protein/nucleotide sequence database, Swiss-Prot, PFAM database, the Gene Ontology database, and the Kyoto Encyclopedia of Genes and Genomes database in order to annotate gene descriptions, associate them with gene ontology terms, and assign them to pathways. The expression patterns for genes involved in several molecular events critical for molting, such as hormone regulation, triggering events, implementation phases, skelemin, immune responses were characterized and considered as mechanisms underlying molting in L. vannamei. Comparisons with transcriptomic analyses in other arthropods were also performed. The characterization of major transcriptional changes in genes involved in the molting cycle provides candidates for future investigation of the molecular mechanisms. The data generated in this study will serve as an important transcriptomic resource for the shrimp research community to facilitate gene and genome annotation and to characterize key molecular processes underlying shrimp development.Entities:
Mesh:
Year: 2015 PMID: 26650402 PMCID: PMC4674093 DOI: 10.1371/journal.pone.0144350
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Morphological changes of shrimp uropods during molting stages under a light microscope (400 × magnification).
Observed physical characteristics of each stage were as follows: 1) Inter-molt stage (C stage): mature setal cones and fully-spread epidermis. 2) Pre-molt stage (D stage): D0, a clear margin of epidermal tissue at the base of the setal cones. D1, a clear, narrow zone between the setal cones and the epidermis. D2, a wider clear zone and a wavy edge of epidermis. D3, a wider clear zone, highly wavy edge of epidermis, and a thin, white layer at the edge of the epidermis. D4, a noticeably wider clear zone, serrated edges of epidermis, a light-reflecting white layer at the edge of the epidermis, and parallel-band edepidermis. 3) Post-molt stage (P stage): P1, soft and delicate setae, absence of setal cones. P2, presence of young setal cones.
An overview of sequencing and assembly of the shrimp transcriptome from L. vannamei.
| Sample | Raw Reads | Clean reads | Total mapped | Clean bases | Error(%) | Q20(%) | GC(%) |
|---|---|---|---|---|---|---|---|
|
| 8462163 | 8378139 | 7205223(86.00%) | 0.42G | 0.01 | 98.64 | 50.04 |
|
| 8356671 | 8281105 | 7228674(87.29%) | 0.41G | 0.01 | 98.68 | 50.01 |
|
| 9729632 | 9658189 | 8372908(86.69%) | 0.48G | 0.01 | 98.63 | 50.14 |
|
| 9001963 | 8949633 | 7698406(86.02%) | 0.45G | 0.01 | 98.74 | 49.85 |
|
| 7069133 | 7010089 | 5949698(84.87%) | 0.35G | 0.01 | 98.52 | 46.72 |
|
| 8289817 | 8237292 | 9226254(86.42%) | 0.41G | 0.01 | 98.58 | 46.87 |
|
| 10758027 | 10676498 | 9226254(86.42%) | 0.53G | 0.01 | 98.66 | 49.69 |
|
| 9878904 | 9801263 | 8596987(87.71%) | 0.49G | 0.01 | 98.74 | 48.46 |
|
| 8732484 | 8665896 | 7228584(83.41%) | 0.43G | 0.01 | 98.65 | 51.18 |
|
| 8414766 | 8350596 | 6939910(83.11%) | 0.42G | 0.01 | 98.68 | 50.47 |
|
| 10154005 | 10078307 | 8667790(86.00%) | 0.5G | 0.01 | 98.79 | 50.70 |
|
| 9650580 | 9598685 | 8199145(85.42%) | 0.48G | 0.01 | 98.81 | 50.08 |
|
| 10570861 | 10500814 | 9255363(88.14%) | 0.53G | 0.01 | 98.71 | 50.09 |
|
| 10017393 | 9937550 | 8650085(87.04%) | 0.5G | 0.01 | 98.69 | 50.77 |
|
| 10205898 | 10135988 | 8787490(86.70%) | 0.51G | 0.01 | 98.78 | 49.61 |
|
| 10073944 | 9993119 | 8832160(88.38%) | 0.5G | 0.01 | 98.70 | 49.97 |
Fig 2Differentially expressed genes (DEGs) detected between eight comparisons of adjacent molting stages (C-D0, D0-D1, D1-D2, D2-D3, D3-D4, D4-P1, P1-P2, and P2-C).
The number of up-regulated and down-regulated genes between comparisons is given. The x-axis indicates adjacent stages in comparisons. The y-axis indicates the number of DEGs.
Fig 3The top five clusters determined by K-means clustering, including 2,999 DEGs (58.6% of all genes).
The x-axis indicates the molting stage. The y-axis indicates the log2(ratio) of gene expression. Each grey row represents the relative expression of DEGs in a cluster. The blue line represents the average value of all members. The red line denotes reference, the line above the red line represents up-regulation, and the line below the red line represents down-regulation. The number of DEGs within a cluster is shown after that subcluster.
Fig 4Gene ontology (GO) classification of all DEGs.
The results are summarized in three main GO categories (cellular component, molecular function, and biological process). The x-axis represents GO subcategories. The left y-axis indicates the percentage of genes. The right y-axis indicates the number of DEGs.
Significantly changed Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways at pre-molt (D4–P1) and post-molt stages revealed by RNA-sequencing.
| D4-P1 | P1-P2 | |||||
|---|---|---|---|---|---|---|
| Top 10 of member quantity | Top 10 of up-regulated pathway | Top 10 of down-regulated pathways | Top 10 of member quantity | Top 10 of up-regulated pathways | Top 10 of down-regulated pathways | |
|
| Lysosome (55) | Tight junction (65566) | Pancreatic secretion (-15672) | Lysosome (33) | Pancreatic secretion (13332) | Tight junction (-74056) |
|
| Phagosome (22) | Focal adhesion (20354) | Protein digestion and absorption (-15559) | Metabolism of xenobiotics by cytochrome P450 (16) | Protein digestion and absorption (13067) | Adrenergic signaling in cardiomyocytes (-25196) |
|
| Amino sugar and nucleotide sugar metabolism (21) | Leukocyte transendothelial migration (19990) | Neuroactive ligand-receptor interaction (-13096) | Drug metabolism—cytochrome P450 (15) | Neuroactive ligand-receptor interaction (11855) | Focal adhesion (-24518) |
|
| Glutathione metabolism (20) | Regulation of actin cytoskeleton (19556) | Lysosome (-10954) | Amino sugar and nucleotide sugar metabolism (15) | Complement and coagulation cascades (9913) | Leukocyte transendothelial migration (-23530) |
|
| Starch and sucrose metabolism (18) | Adrenergic signaling in cardiomyocytes (18211) | Complement and coagulation cascades (-10834) | Glutathione metabolism (14) | Lysosome (9024) | Regulation of actin cytoskeleton (-23032) |
|
| Peroxisome (17) | Cardiac muscle contraction (16315) | Antigen processing and presentation (-7150) | Starch and sucrose metabolism (13) | Ribosome (7665) | Cardiac muscle contraction (-22476) |
|
| Other glycan degradation(16) | Phototransduction- fly (13935) | Ribosome (-6336) | Sphingolipid metabolism (11) | Amino sugar and nucleotide sugar metabolism (5726) | Phototransduction–fly (-14495) |
|
| Carbon metabolism (16) | Oxytocin signaling pathway (13035) | Oxidative phosphorylation (-4876) | Peroxisome (11) | Antigen processing and presentation (5712) | Oxytocin signaling pathway (-14393) |
|
| Galactose metabolism (15) | Rap1 signaling pathway (12426) | Amino sugar and nucleotide sugar metabolism (-4854) | Galactose metabolism (10) | Oxidative phosphorylation (3876) | Rap1 signaling pathway (-13989) |
|
| Glycerolipid metabolism (14) | Adherens junction (12098) | Carbohydrate digestion and absorption (-4516) | Arachidonic acid metabolism (10) Biosynthesis of amino acids (10) | Protein processing in endoplasmic reticulum (2354) | Adherens junction (-13081) |
The top 10 up-regulating pathways and top 10 down-regulating pathways were identified by subtracting the fragments per kilobase of exon per million fragments mapped (FPKM) of D4 from P1 (P1 − D4) and P1 from P2 (P2 − P1). Digits in brackets indicate the number of differentially expressed genes (DEGs) and conversion of FPKM.
Gene expression data and descriptions of 11 CHH- and MIH-related genes in the molting cycle.
| Gene_id | Description | Expression | |||||||
|---|---|---|---|---|---|---|---|---|---|
| C | D0 | D1 | D2 | D3 | D4 | P1 | P2 | ||
|
|
| 0 | 0.36 | 0.46 |
|
| 0 | 0 | 0.31 |
|
|
| 1.11 | 0.26 | 1.85 |
|
| 1.05 | 1.36 | 1.60 |
|
|
| 0.25 | 0 | 0.30 | 0 | 0 | 0 | 0.39 | 0.41 |
|
| molt-inhibiting hormone 1 | 0 | 0.38 | 0 |
|
| 0 | 1.59 | 0.66 |
|
|
| 0.86 | 1.22 | 1.86 |
|
| 0.17 | 0.88 | 0.63 |
|
| hyperglycemic hormone-like peptide precursor | 3.36 | 2.53 | 2.14 |
|
| 14.33 | 5.31 | 2.98 |
|
| Crustacean hyperglycemic hormone precursor | 6.56 | 4.26 | 3.63 |
|
| 4.38 | 11.61 | 3.85 |
|
| Crustacean hyperglycemic hormones 4 | 0.47 | 0.21 | 0.94 |
|
| 0 | 0.68 | 0.58 |
|
| Crustacean hyperglycemic hormone-like peptide precursor | 0.71 | 1.15 | 1.15 |
|
| 1.70 | 4.99 | 2.93 |
|
| Crustacean hyperglycemic hormones 2 | 6.01 | 3.66 | 3.24 |
|
| 3.72 | 7.05 | 3.68 |
|
| Crustacean hyperglycemic hormone 3 precursor | 0 | 0 | 0.34 | 0 | 0 | 0 | 0 | 0.12 |
Expressions levels are represented by fragments per kilobase of exon per million fragments mapped (FPKM) at each stage. Bold text denotes down-regulation at D2 and D3. Changes in c65241_g1 expression between D2 and D3 meet the criterion of differentially expressed genes (log2ratio ≥1 and FDR ≤0.001).
Expression levels of hormone related molting genes.
| Factor name | Gene Number | Expression | Gene ID | Reference | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| C | D0 | D1 | D2 | D3 | D4 | P1 | P2 | ||||
| Ecdysteroid regulated-like protein | 6 | 678.42 | 715.77 | 671.63 | 366.40 |
|
| 57.31 | 672.91 | c19570_g1 c81580_g1 c65832_g1 c72607_g1 c74657_g1 c106886_g1 | Margam |
| Molting fluid carboxypeptidase | 4 | 13.04 | 12.32 | 11.83 | 16.76 |
|
| 19.61 | 13.34 | c80306_g1 c74916_g2 c69559_g1 c64320_g1 | Ote |
| Ecdysone receptor (ECR) | 2 | 11.6 | 12.48 | 15.19 | 22.34 |
|
| 11.35 | 14.66 | c72141_g9 c75175_g1 | Durica |
| Ecdysone-induced protein 74EF | 1 | 4.30 | 3.65 | 3.31 | 20.40 |
|
| 6.33 | 4.70 | c70692_g1 | Burtis |
| Ecdysteroid receptor E75 | 1 | 21.94 | 13.04 | 13.60 | 12.17 |
|
| 25.76 | 16.57 | c76549_g1 | Priya |
| Ecdysone-induced protein 78 | 1 | 0.28 | 0.31 | 0.23 | 0.60 |
|
| 0.37 | 0.35 | c78631_g1 | Wu |
| Retinoid-X receptors (RXR) | 2 | 8.95 | 9.09 | 10.42 | 10.34 |
|
| 18.01 | 13.03 | c74810_g1 c74810_g2 | Priya |
| Methyl farnesoate(MF) | 1 | 15.79 | 12.15 | 10.02 | 8.51 |
|
| 13.51 | 23.06 | c40589_g1 | Borst |
| Farnesoic acid (FA) | 2 | 459.21 | 478.11 | 335.73 | 300.28 |
|
| 154.61 | 412.46 | c69785_g1 c75001_g2 | Li |
| Vitellogenin gene (VG) | 5 | 52.00 | 126.24 | 99.32 | 34.45 |
|
| 29.21 | 55.32 | c129870_g1 c47984_g2 c72701_g1 c79730_g7 c83835_g1 | Shechter |
| 17-beta-dehydrogenase | 1 | 31.60 | 21.34 | 27.54 | 19.91 |
|
| 3.24 | 32.56 | c71230_g1 | Mindnich |
| Pigment dispersing hormone (PDH) | 1 | 3.93 | 2.97 | 3.18 | 3.66 |
|
| 4.39 | 2.70 | c82344_g1 | Christie |
| Red pigment-concentrating hormone (RPCH) | 1 | 4.99 | 5.28 | 2.81 | 4.96 |
|
| 7.11 | 3.11 | c37749_g1 | Sathapondecha |
Molting hormone-related factors and fragments per kilobase of exon per million fragments mapped (FPKM) are shown for each stage. Expression represents the FPKM value of combined factors. Bold text denotes up-regulated expression in D3 and D4. The reports about genes related to molting hormone were used as the reference.
Expression levels of actin, myosin and troponin genes.
| gene_id | Expression | Description | |||||||
|---|---|---|---|---|---|---|---|---|---|
| C | D0 | D1 | D2 | D3 | D4 | P1 | P2 | ||
|
| |||||||||
| c82047_g1 | 20849.17 | 11760.99 | 8767.04 | 17445.72 | 37490.78 |
|
| 12889.42 | actin T2 [ |
| c78558_g1 | 19381.33 | 12253.83 | 11127.16 | 15866.74 | 29958.74 |
|
| 13282.95 | skeletal muscle actin 6 [ |
| c82047_g2 | 5452.26 | 4508.13 | 3889.94 | 5610.92 | 7692.16 |
|
| 4280.14 | actin [ |
| c1146_g1 | 551.34 | 356.10 | 353.85 | 522.41 | 1019.68 |
|
| 442.82 | PREDICTED: similar to alpha actinin CG4376-PB [ |
| c64985_g1 | 582.23 | 285.86 | 189.72 | 431.65 | 1147.69 |
|
| 349.84 | beta-actin [ |
| c67471_g1 | 5305.29 | 5754.25 | 4079.25 | 5732.58 | 4737.16 | 5551.05 | 4644.41 | 5148.22 | actin E [ |
|
| |||||||||
| c26953_g1 | 18358.27 | 9826.73 | 8751.77 | 13851.15 | 30821.99 |
|
| 11310.27 | myosin light chain [ |
| c61912_g2 | 17348.02 | 8694.49 | 5830.68 | 12411.85 | 29644.34 |
|
| 10038.46 | myosin light chain 2 [ |
| c83685_g5 | 6013.84 | 3319.11 | 3139.47 | 5724.11 | 10316.04 |
|
| 4013.95 | myosin heavy chain type a [ |
| c83685_g6 | 5284.95 | 3459.07 | 2954.50 | 4903.49 | 9770.18 |
|
| 3898.41 | myosin heavy chain [ |
| c83685_g2 | 5493.96 | 3169.90 | 2752.71 | 4762.17 | 10266.71 |
|
| 3497.44 | myosin heavy chain type 2 [ |
| c71354_g2 | 5380.86 | 3220.31 | 2368.17 | 4408.20 | 8691.22 |
|
| 3648.19 | Tropomyosin |
| c59746_g1 | 4283.22 | 2365.53 | 2251.28 | 3796.17 | 8245.85 |
|
| 2700.07 | myosin heavy chain type b [ |
| c83685_g3 | 3713.36 | 1950.47 | 1416.29 | 3185.80 | 6668.01 |
|
| 2330.42 | myosin heavy chain type a [ |
| c83685_g7 | 3350.25 | 1845.41 | 1403.93 | 3129.62 | 6009.07 |
|
| 2277.59 | myosin heavy chain type 1 [ |
| c80445_g4 | 2002.07 | 1569.03 | 1140.62 | 2575.80 | 2775.48 |
|
| 2244.00 | myosin heavy chain type a [ |
| c73388_g1 | 3341.68 | 1750.24 | 1518.60 | 2894.58 | 5650.37 |
|
| 2141.69 | myosin heavy chain type 1 [ |
| c72756_g3 | 3191.01 | 1910.18 | 1279.89 | 3158.56 | 5343.45 |
|
| 2172.07 | myosin heavy chain type b [ |
| c83685_g1 | 2957.29 | 1762.68 | 1486.49 | 2904.02 | 5242.33 |
|
| 1990.97 | myosin heavy chain type 2 [ |
| c56242_g1 | 1817.63 | 1214.37 | 817.26 | 1998.79 | 2457.60 |
|
| 1696.15 | myosin heavy chain [ |
| c83685_g4 | 2487.71 | 1667.46 | 1287.52 | 2516.83 | 4704.41 |
|
| 1842.34 | myosin heavy chain type 2 [ |
| c28182_g1 | 1241.64 | 957.46 | 468.61 | 2004.75 | 1439.54 |
|
| 1532.49 | myosin heavy chain type 1 [ |
| c70174_g1 | 1293.27 | 989.18 | 687.60 | 1728.27 | 1600.99 |
|
| 1419.61 | myosin heavy chain type a [ |
| c81295_g1 | 2174.39 | 1454.10 | 1238.15 | 2324.49 | 3751.85 |
|
| 1608.96 | myosin heavy chain type 2 [ |
| c72756_g5 | 1906.57 | 1181.00 | 855.85 | 2022.35 | 3457.55 |
|
| 1386.27 | myosin heavy chain type 2 [ |
| c80636_g6 | 1173.97 | 834.21 | 622.22 | 1483.74 | 1867.45 |
|
| 1055.14 | myosin heavy chain type a [ |
| c73679_g4 | 1287.09 | 1064.99 | 891.33 | 1744.40 | 2259.05 |
|
| 1179.03 | myosin heavy chain type 2 [ |
| c75308_g3 | 1160.26 | 763.11 | 581.75 | 1150.50 | 2075.74 |
|
| 939.38 | myosin heavy chain [ |
| c65216_g3 | 762.80 | 614.08 | 496.68 | 1087.12 | 929.43 |
|
| 845.22 | myosin heavy chain type 1 [ |
| c54630_g1 | 757.96 | 388.83 | 381.84 | 901.29 | 1239.59 |
|
| 570.87 | myosin heavy chain type 2 [ |
| c80636_g3 | 606.17 | 465.76 | 292.61 | 874.87 | 637.77 |
|
| 692.98 | myosin heavy chain type 1 [ |
| c67474_g3 | 658.03 | 537.14 | 522.17 | 708.15 | 885.97 |
|
| 547.11 | myosin heavy chain type b [ |
| c131544_g1 | 1001.89 | 456.89 | 474.76 | 748.11 | 1719.62 |
|
| 506.46 | myosin heavy chain type 1 [ |
| c76934_g4 | 241.76 | 231.68 | 124.32 | 237.08 | 148.35 |
|
| 343.57 | myosin light chain [ |
| c80445_g3 | 1158.72 | 660.06 | 569.76 | 983.21 | 2504.93 |
|
| 727.07 | myosin heavy chain type a [ |
| c61703_g1 | 577.82 | 370.49 | 161.21 | 639.87 | 840.82 |
|
| 496.98 | myosin heavy chain type 1 [ |
| c56973_g1 | 723.62 | 583.59 | 743.88 | 622.63 | 1086.04 |
|
| 588.23 | myosin heavy chain type a [ |
| c26953_g2 | 15234.89 | 7968.36 | 5883.06 | 11377.27 | 25713.28 |
|
| 9214.75 |
|
| c60870_g1 | 457.39 | 207.31 | 203.58 | 266.65 | 1093.96 |
|
| 176.09 | myosin heavy chain type 1 [ |
| c49254_g1 | 461.37 | 176.57 | 179.47 | 261.17 | 1069.88 |
|
| 168.66 | myosin heavy chain type a [ |
| c44371_g1 | 800.12 | 582.47 | 469.72 | 675.81 | 1261.00 |
|
| 610.90 | paramyosin [ |
| c75308_g4 | 652.67 | 368.88 | 264.29 | 572.09 | 1413.10 |
|
| 469.15 | myosin heavy chain [ |
| c44674_g2 | 617.30 | 446.94 | 628.45 | 518.82 | 1321.63 |
|
| 410.36 | muscle myosin heavy chain [ |
| c73679_g12 | 679.31 | 360.95 | 342.99 | 551.67 | 1214.87 |
|
| 405.63 | myosin heavy chain type 2 [ |
| c54360_g1 | 686.35 | 447.84 | 349.10 | 491.94 | 1021.10 |
|
| 468.13 | myosin heavy chain isoform 3 [ |
|
| |||||||||
| c70761_g2 | 7319.28 | 4474.64 | 3958.16 | 6386.01 | 12737.54 |
|
| 5377.96 | Troponin T [ |
| c59125_g1 | 7150.50 | 3794.77 | 3426.53 | 5099.38 | 10466.81 |
|
| 4293.31 | troponin I [ |
| c81020_g2 | 1656.78 | 878.59 | 824.72 | 1419.39 | 1964.06 |
|
| 1118.01 | troponin C1 [ |
| c81020_g3 | 800.81 | 349.56 | 280.64 | 353.36 | 1150.26 |
|
| 321.51 | troponin C [ |
Skelemin related factors and fragments per kilobase of exon per million fragments mapped (FPKM) are shown for each stage. Bolded text denotes up-regulated expression in D4-P1.
Fig 5Hierarchical clustering of 236 immunity genes.
Colored keys represent the fold changes (log2 transformed counts) of gene expression between adjacent molt stages Red represents up-regulation and green represents down-regulation. Each column represents an experimental condition (e.g. C-D0), and each row represents an immunity gene.
Fig 6Expression profiles of hemocyanin, serine proteinase, trypsin, chymotrypsin, and chitinase.
The x-axis represents developmental stages. The line represents the total fragments per kilobase of exon per million fragments mapped (FPKM) for the genes.
Fig 7Real-time quantitative PCR (qRT-PCR).
Six candidate genes were selected randomly for validation. Expression results of qRT-PCR are shown on the left and expression profiles of RNA-sequencing on the right. The gene c82047_g1 (Actin T2) was used as the control reference gene.
Fig 8A cascade of molecular events applicable to the molting cycle of L. vannamei.
This figure depicts the molecular events identified in this study in relation to the morphological diversification of molting in a diagrammatic sketch. The rhombi represent molecular events occurring in the molting process. The x-axis represents molting stages.